Cardio-Oncology: Fluoropyrimidine Chemotherapy Treatment with 5-fluorouracil (5FU) or capecitabine

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Cardiac Dysfunction in Childhood Cancer Survivors

Conditions:   Cardiac Dysfunction;   Cardiovascular Diseases;   Childhood Cancer
Intervention:   Diagnostic Test: cardiac assessment
Sponsors:   University of Bern;   University Children's Hospital Basel
Recruiting

Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During Prehabilitation

Condition:   Non Small Cell Lung Cancer
Intervention:   Other: Preoperative Pulmonary Rehabilitation
Sponsor:   ADIR Association
Recruiting

The BRAvAdO Registry

Conditions:   ACS - Acute Coronary Syndrome;   Oncology
Intervention:  
Sponsors:   University of Sao Paulo General Hospital;   Instituto do Cancer do Estado de São Paulo;   Beneficência Portuguesa de São Paulo;   Instituto de Cardiologia do Rio Grande do Sul;   InCor Heart Institute
Recruiting

Non-interventional Study on Patients With Atrial Fibrillation and Cancer

Conditions:   Atrial Fibrillation;   Cancer
Intervention:  
Sponsor:   Heart Care Foundation
Recruiting

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Active, not recruiting

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Condition:   Non-Small-Cell Lung
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Placebo Comparator;   Drug: Nab-paclitaxel;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine
Sponsor:   Hoffmann-La Roche
Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung
Interventions:   Drug: Alectnib;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin
Sponsor:   Hoffmann-La Roche
Recruiting

A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Condition:   Cancer
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Recruiting

A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Condition:   Carcinoma, Non-Small-Cell Lung
Intervention:   Drug: Atezolizumab
Sponsor:   Hoffmann-La Roche
Recruiting

A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Etoposide
Sponsor:   Hoffmann-La Roche
Recruiting